Nano Dimension activists press to oust three directors, install new slate at July 31 vote

Nano Dimension faces a shareholder activist campaign led by Murchinson, Nomis Bay, and others to oust three directors and install new nominees at the July 31, 2026 meeting. The board opposes these removal proposals but supports declassifying the board and continues reviewing strategic alternatives, including potential asset sales.

Nano Dimension will hold an extraordinary shareholder meeting on July 31, 2026 following a demand led by Murchinson, Nomis Bay, Boothbay funds, BPY, Oramed. * Board backs a non-binding vote to continue its strategic alternatives review, citing asset sales and a non-binding term sheet with Infinite Epigenetics. * Board supports a shareholder proposal to declassify the board, which requires 70% of votes cast at the meeting. * Board opposes proposals to require shareholder approval for any rights plan, mandate votes on certain major transactions, remove three directors, elect three new nominees. * Meeting record date is June 23, 2026; proposals are non-routine so brokers cannot vote uninstructed shares. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Nano Dimension Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0000930413-26-001947), on June 25, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here

Nano Dimension will hold an extraordinary shareholder meeting on July 31, 2026 following a demand led by Murchinson, Nomis Bay, Boothbay funds, BPY, Oramed. * Board backs a non-binding vote to continue its strategic alternatives review, citing asset sales and a non-binding term sheet with Infinite Epigenetics. * Board supports a shareholder proposal to declassify the board, which requires 70% of votes cast at the meeting. * Board opposes proposals to require shareholder approval for any rights plan, mandate votes on certain major transactions, remove three directors, elect three new nominees. * Meeting record date is June 23, 2026; proposals are non-routine so brokers cannot vote uninstructed shares. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Nano Dimension Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0000930413-26-001947), on June 25, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here